Development of monoclonal antibodies to prevent and treat Flavivirus infections (HORIZON-HLTH-2027-01-DISEASE-06)
Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
- Closes
- 17 Feb 2027
- 95 days left
- Opened
- 29 Oct 2026
- Who can apply
- Research organisations, Large companies, SMEs, Consortia
- Open to applicants from
- European Union
What this call funds
Horizon Europe Cluster 1 Health call to advance existing prophylactic and therapeutic monoclonal antibody candidates against one specified Flavivirus, such as Dengue, Tick-borne Encephalitis, Japanese Encephalitis, West Nile, Yellow Fever or Zika. Applicants must name the single virus targeted. The call opens 29 October 2026 with a single-stage deadline of 17 February 2027 at 17:00 CET, and applications are submitted via the Funding and Tenders Portal.
The call in detail
- Funder
- HaDEA
- Programme
- Horizon Europe Cluster 1: Health
- Type
- Grant
- Eligible applicants
- Research organisations, Large companies, SMEs, Consortia
- Eligible countries
- European Union
- Startup relevance
- Low
- Source
- HaDEA — calls for proposals
Key dates
- 29 Oct 2026
- Applications opened
- 17 Feb 2027
- Applications close
Earlier rounds and changes
| Recorded | What changed | Details |
|---|---|---|
| 13 Nov 2026 | First listed here | Already listed when the source was first read |
Similar open calls
Open calls like this one are listed for free accounts. Start with a free account to see them, save searches and get an e-mail when a new call matches.
Create free accountSummaries and extracted fields are generated automatically from the official page and may contain mistakes. Check the official page before applying.